TaiDoc Technology (TPE:4736) ROCE %: 17.10% (As of Dec. 2025)


TPE:4736 TaiDoc Technology Corp TPE:4736
73 GF Score
Price NT$123.00
GF Value NT$111.99
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is TaiDoc Technology ROCE %?

TaiDoc Technology TPE:4736 -1.20% 73 ROCE % is 17.10% as of Dec. 2025. GuruFocus rates TPE:4736 with a GF Score™ of 73/100 and a GF Value™ of NT$111.99 (Fairly Valued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. TaiDoc Technology's annualized ROCE % for the quarter that ended in Dec. 2025 was 17.10%.

TaiDoc Technology  (TPE:4736) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

TaiDoc Technology ROCE % Related Terms

TaiDoc Technology ROCE % Historical Data

* Premium members only.

The historical data trend for TaiDoc Technology's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TaiDoc Technology ROCE % Chart

TaiDoc Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.59 47.58 13.40 15.23 17.02

TaiDoc Technology Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.20 1.47 24.00 29.34 17.10
TPE:4736
73GF Score
TaiDoc Technology Corp TPE:4736
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TaiDoc Technology ROCE % Calculation

TaiDoc Technology's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=1723.227/( ( (12239.687 - 2394.59) + (12784.458 - 2380.909) )/ 2 )
=1723.227/( (9845.097+10403.549)/ 2 )
=1723.227/10124.323
=17.02 %

TaiDoc Technology's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=1746.164/( ( (12790.497 - 2774.554) + (12784.458 - 2380.909) )/ 2 )
=1746.164/( ( 10015.943 + 10403.549 )/ 2 )
=1746.164/10209.746
=17.10 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 17.10% mean?
TaiDoc Technology (TPE:4736) has a ROCE % of 17.10% as of Dec. 2025.
Is TaiDoc Technology's ROCE % too high?
TaiDoc Technology's current ROCE % is 17.10%. The Medical Devices & Instruments industry median ROCE % is 2.23. TaiDoc Technology's value of 17.10% is 666.8% above this industry median. Overall, TaiDoc Technology has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does TaiDoc Technology's ROCE % compare to ABT and SYK?
TaiDoc Technology's ROCE % of 17.10% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. TaiDoc Technology's value of 17.10% is 666.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TaiDoc Technology's current ROCE % of 17.10% is 666.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TaiDoc Technology's current ROCE % is 17.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TaiDoc Technology stock overvalued right now?
Based on GuruFocus' analysis, TaiDoc Technology (TPE:4736) is currently considered Fairly Valued. The stock's GF Value™ is NT$111.99, compared to a current price of NT$123.00 — trading 9.8% above its estimated fair value. The current ROCE % is 17.10% and 666.8% above the Medical Devices & Instruments industry median of 2.23. TaiDoc Technology's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For TaiDoc Technology (TPE:4736), the current ROCE % is 17.10% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TaiDoc Technology (TPE:4736) Overvalued in 2026?

Based on GuruFocus' analysis, TaiDoc Technology stock appears to be overvalued. The current stock price of NT$123.00 is trading 9.8% above its estimated GF Value™ of NT$111.99. GuruFocus considers TaiDoc Technology to be Fairly Valued.

Key valuation signals for TPE:4736:

  • ROCE %: 17.10%
  • GF Value™: NT$111.99 vs. price of NT$123.00 (9.8% above fair value)
  • GF Score™: 73/100 with 4 warning signs
  • Industry Position: 666.8% above the Medical Devices & Instruments median

No single metric tells the full story. See the TPE:4736 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TaiDoc Technology Business Description

Address Wugong 2nd Road, 6th Floor, No. 127, Wugu District, New Taipei City, TWN, 24888
TaiDoc Technology Corp is engaged in the research and development, manufacture, and sales of various electronics components and medical devices. Its products and services include In Vitro Diagnostic, Medical Device, and TeleHealth. It has three segments: Manufacturing of Medical Devices, Precision Finishing Division, and Sales of Medical Devices. It derives the majority of its revenue from the Manufacturing of Medical Devices. Geographically, the company derives its key revenue from Europe and the rest from the Americas, the Middle East, Asia, Taiwan, and others.
73GF Score

Get the complete analysis for TPE:4736

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$123.00
Price
NT$111.99
GF Value